Literature DB >> 3748255

Verapamil in arterial hypertension with renal disease.

R Boero, F Quarello, C Guarena, G Piccoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3748255     DOI： 10.1159/000183918

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  4 in total

1.  Sustained release verapamil in renal hypertension.

Authors:  H Eiskjaer; E B Pedersen; L M Rasmussen; B Jespersen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

3.  Is renal protection with calcium antagonists possible?

Authors:  P García-Cosmes; A Mortezo; J M López-Novoa; J F Macías-Núñez
Journal:  Drugs       Date:  1992       Impact factor: 9.546

4.  Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure.

Authors:  D C Schohn; H A Jahn; M Maareck
Journal:  Drugs       Date:  1993       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.